Logo of Phnom Penh Post newspaper Phnom Penh Post - New weapons available in fight against cancer

New weapons available in fight against cancer

Content image - Phnom Penh Post
Battles may slowly be starting to turn in the never-ending war against cancer. AFP

New weapons available in fight against cancer

More effective therapies, nanotechnology and even the prospect of vaccinating for certain tumours: battles may slowly be starting to turn in the never-ending war against cancer.

The second leading cause of death globally, cancer accounted for an estimated 9.6 million deaths, or one in six deaths, in 2018.

In observance of World Cancer Day on February 4, here is a look at some of the more promising developments in treating and preventing the disease.

Immunotherapy breakthroughs

Immunotherapy drugs, which prime the immune system to recognise and destroy cancerous cells, have shown huge promise against previously untreatable cancers over the last decade.

But they vary greatly among different forms of cancer and only work in around a quarter of all patients.

A main focus of research now centres on “increasing the percentage of patients that respond well to immunotherapy,” according to Christophe Le Tourneau, director of clinical research at France’s Curie Institute.

One promising avenue is the development of antibodies capable of recognising a specific protein found in cancerous cells, “which would help the body to destroy those cells,” said Axel Kahn, president of the League Against Cancer.

He said research had shown that administering medication or toxins helped destroy cancer cells after antibodies discover them.

Research is also ongoing into immunotherapy after chemotherapy, with the initial treatment creating mutations in cancer cells that may render them easier for the immune system to spot and hunt down.

Another technique known as checkpoint inhibitor therapy has also shown promise.

When proteins contained within cancer cells bind with immune cells, they send an “off” signal to the rest of the immune system, disabling the body’s natural defences.

Checkpoint inhibitor therapy essentially blocks this binding, allowing killer immune T-cells to seek and destroy the pathogen.

This technique has already significantly improved prognoses for some melanomas and lung cancers, and other trials are underway.

Such treatment may offer also hope to the 10-15 per cent of breast cancer sufferers who receive a so-called “triple-negative” prognoses – tumours that contain neither hormonal nor HER2 protein receptors.

HER2-positive breast cancer tends to grow more quickly than other forms but it is equally more treatable.

Triple-negative breast cancer is however “usually more aggressive [but] the treatment options available today are not sufficiently effective”, according to the Arc Foundation cancer research centre near Paris.

One study with the drug durvalumab published this month in Nature Medicine showed that the antibody was somewhat effective at shutting off tumours’ ability to evade the immune system.

‘Vaccinate’ for tumours?

Trials are also underway exploring the efficacy of certain candidate vaccines that can help treat tumours.

The French biotech firm Transgene is developing a treatment combining immunotherapy and a viral vector vaccine – a modified virus that delivers anti-cancer instructions to the body.

A similar trial is underway to treat patients with cancer of the ear, nose or throat.

The Oncopole Toulouse cancer treatment centre, conducting the research, said the treatment acts as a kind of “facial recognition service” for the immune system to detect cancerous cells and learn how to destroy them – similar to how some vaccines work.

Predicting effective treatment

Analysing the structure and, increasingly, the genetic make-up of cancer plays a major role not only in prognosis – how likely it is that a patient will recover – but also in what treatment options are available.

“It’s really the main issue – it’s not worth giving certain treatments to people who won’t benefit from them and it’s absolutely crucial that those who will benefit receive them, said Eric Solary, scientific director at the Arc Foundation.

Better understanding of certain mutations in cancer cells as well as how immune cells behave are helping doctors make ever-more accurate treatment choices.


Another area of growing interest is the possible use of nanocapsules – microscopic coatings of metal or fat on existing drug molecules.

The idea according to Solary is to better distribute medicine around the patient’s body by allowing it to “go directly into tumour cells and avoiding damaging normal cells”.

In the same vein, researchers are also looking into using genetically modified salmonella bacteria to destroy tumours from the inside out – where more traditional treatments, notably chemotherapy, cannot penetrate.


  • Chinese firms unveil preliminary results on metro, monorail for capital

    Minister of Public Works and Transport Sun Chanthol and representatives from China Road and Bridge Corp (CRBC) and its parent company, the state-owned China Communications Construction Co Ltd (CCCC), met on June 24 for talks on results of the firms’ preliminary study on a potential metro

  • Num banh chok pizza a new fusion hit

    Num banh chok is a traditional fish curry with fermented rice noodles, prahok fish paste, kroeung paste, flowering plants and seasonal vegetables that is arguably a strong contender for “national dish” status in Cambodia and typically served for breakfast or eaten as an afternoon snack.

  • Cambodia detects new Covid cases after 52 days: PM

    After 52 days of zero new Covid-19 cases, Cambodia has now detected new infections, according to Prime Minister Hun Sen. In his special audio address to the nation late on June 28, Hun Sen said the new cases were detected on people who had undergone PCR tests

  • Higher education leaders tour US

    With support from the US Department of State, 10 Cambodian leaders in higher education participated in the 10-day International Visitors Leadership Programme (IVLP) in three US states from June 19 to July 1. They included nine university rectors and directors of higher education institutions who are members of

  • Gold-covered boundary stone found within Angkor Thom’s West Gate

    The Apsara National Authority (ANA) announced that their working group in charge of restoration work at Angkor Thom's Takav Gate or the West Gate recently found an ancient stone slab commonly known as a boundary stone. The boundary stone is 53 cm by 53 cm and 12 cm

  • Angkor ticket sales jump by 1,000 per cent in the first half

    Angkor Archaeological Park netted more than $2.4 million from ticket sales in the first half of 2022, an increase of more than 1,000 per cent year-on-year, Angkor Enterprise reported. According to a July 1 statement issued by Angkor Enterprise, the state-run institution that manages tickets sales for international visitors